• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人内皮细胞中组织型纤溶酶原激活物受体(t-PAR)的分析

Analysis of tissue-type plasminogen activator receptor (t-PAR) in human endothelial cells.

作者信息

Fukao H, Matsuo O

机构信息

Department of Physiology, Kinki University School of Medicine, Osakasayama City, Osaka, Japan.

出版信息

Semin Thromb Hemost. 1998;24(3):269-73. doi: 10.1055/s-2007-995853.

DOI:10.1055/s-2007-995853
PMID:9701459
Abstract

Vascular endothelial cells regulate the fibrinolytic system in blood by expressing cell-surface receptors for plasminogen and plasminogen activators (PAs) as well as secreting PAs and their inhibitors. Although several receptors for plasminogen and PAs have been identified in many cell types, little is known about tissue-type PA (t-PA)-specific receptor (t-PAR) on endothelial cells except a few reports. By using suspended human umbilical vein endothelial cells (HUVEC), which are free from the formation of extracellular matrix (ECM)--where type-1 plasminogen activator inhibitor (PAI-1) preferably accumulates and interacts with t-PA with high affinity--we demonstrated a relatively low affinity binding site for t-PA on the cells and identified a novel t-PAR. The isolation and characterization of HUVEC-derived t-PAR was performed in the present study. A 20-kDa t-PAR was successively isolated and purified by high performance liquid chromatography system from HUVEC which specifically binds t-PA and not plasminogen forming a 90-kDa complex with t-PA. When t-PA binds the immobilized t-PAR stoichiometrically 1:1, the enzymatic activity of t-PA was enhanced 90-fold. Thus, it is suggested that the t-PAR may function as a t-PA-enhancing molecule expressed on the surface of endothelial cells.

摘要

血管内皮细胞通过表达纤溶酶原和纤溶酶原激活剂(PAs)的细胞表面受体以及分泌PAs及其抑制剂来调节血液中的纤维蛋白溶解系统。尽管在许多细胞类型中已鉴定出几种纤溶酶原和PAs的受体,但除了少数报道外,关于内皮细胞上组织型PA(t-PA)特异性受体(t-PAR)的了解甚少。通过使用悬浮的人脐静脉内皮细胞(HUVEC),这些细胞不会形成细胞外基质(ECM)——1型纤溶酶原激活剂抑制剂(PAI-1)优选在其中积累并与t-PA以高亲和力相互作用——我们证明了细胞上存在相对低亲和力的t-PA结合位点,并鉴定出一种新型t-PAR。本研究对HUVEC衍生的t-PAR进行了分离和表征。通过高效液相色谱系统从HUVEC中依次分离并纯化出一种20 kDa的t-PAR,它特异性结合t-PA而非纤溶酶原,并与t-PA形成90 kDa的复合物。当t-PA与固定化的t-PAR以1:1的化学计量比结合时,t-PA的酶活性增强了90倍。因此,提示t-PAR可能作为一种在内皮细胞表面表达的t-PA增强分子发挥作用。

相似文献

1
Analysis of tissue-type plasminogen activator receptor (t-PAR) in human endothelial cells.人内皮细胞中组织型纤溶酶原激活物受体(t-PAR)的分析
Semin Thromb Hemost. 1998;24(3):269-73. doi: 10.1055/s-2007-995853.
2
Ethanol-induced up-regulation of the urokinase receptor in cultured human endothelial cells.乙醇诱导培养的人内皮细胞中尿激酶受体上调。
Alcohol Clin Exp Res. 2001 Feb;25(2):163-70.
3
Effect of heat shock on the expression of urokinase-type plasminogen activator receptor in human umbilical vein endothelial cells.热休克对人脐静脉内皮细胞中尿激酶型纤溶酶原激活物受体表达的影响。
Thromb Haemost. 1996 Feb;75(2):352-8.
4
The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein.尿激酶型纤溶酶原激活剂、其受体及1型尿激酶型纤溶酶原激活剂抑制剂对卡波西肉瘤和毛细血管内皮细胞体外生长及侵袭的影响:HIV-Tat蛋白的作用
Int J Oncol. 2005 Jul;27(1):223-35.
5
Plasminogen activator inhibitor 1 contains a cryptic high affinity receptor binding site that is exposed upon complex formation with tissue-type plasminogen activator.纤溶酶原激活物抑制剂1含有一个隐蔽的高亲和力受体结合位点,该位点在与组织型纤溶酶原激活物形成复合物时暴露出来。
Thromb Haemost. 1998 Nov;80(5):822-8.
6
Determinants of induction of increased synthesis of plasminogen activator inhibitor type-1 in human endothelial cells by t-PA.组织型纤溶酶原激活物诱导人内皮细胞中1型纤溶酶原激活物抑制剂合成增加的决定因素。
Thromb Haemost. 1992 Feb 3;67(2):233-8.
7
Enhancement of tissue-type plasminogen activator (t-PA) activity by purified t-PA receptor expressed in human endothelial cells.
Biochim Biophys Acta. 1997 Mar 27;1356(1):111-20. doi: 10.1016/s0167-4889(96)00162-0.
8
Extracellular matrix produced by cultured corneal and aortic endothelial cells contains active tissue-type and urokinase-type plasminogen activators.培养的角膜和主动脉内皮细胞产生的细胞外基质含有活性组织型和尿激酶型纤溶酶原激活剂。
J Cell Physiol. 1993 Mar;154(3):456-65. doi: 10.1002/jcp.1041540303.
9
Induction of synthesis of plasminogen activator inhibitor type-1 by tissue-type plasminogen activator in human hepatic and endothelial cells.组织型纤溶酶原激活物在人肝细胞和内皮细胞中诱导1型纤溶酶原激活物抑制剂的合成。
Thromb Haemost. 1990 Nov 30;64(3):412-9.
10
Single-chain and two-chain tissue-type plasminogen activator (t-PA) bind differently to cultured human endothelial cells.单链和双链组织型纤溶酶原激活剂(t-PA)与培养的人内皮细胞的结合方式不同。
Thromb Haemost. 1989 Sep 29;62(2):699-703.

引用本文的文献

1
Endothelial binding of recombinant tissue plasminogen activator: quantification in vivo using a recirculatory model.重组组织型纤溶酶原激活剂的内皮细胞结合:使用再循环模型进行体内定量分析。
J Pharmacokinet Pharmacodyn. 2003 Feb;30(1):3-22. doi: 10.1023/a:1023293325245.
2
Role of tissue plasminogen activator receptor LRP in hippocampal long-term potentiation.组织纤溶酶原激活物受体LRP在海马体长期增强效应中的作用。
J Neurosci. 2000 Jan 15;20(2):542-9. doi: 10.1523/JNEUROSCI.20-02-00542.2000.